• News

"Mount Sinai Researcher Receives $2.5 Million to Fight Neurodegenerative Disorders"

  • Science Magazine
  • New York, NY
  • (December 07, 2018)

Ivan Marazzi, PhD, assistant professor of microbiology at the Icahn School of Medicine at Mount Sinai, was awarded $2.5 million in funding by the Chan Zuckerberg Initiative (CZI) to further the understanding of the underlying causes of neurodegenerative disorders such as Lou Gehrig’s, Alzheimer’s, and Parkinson’s diseases. The award is part of a $64 million commitment by CZI to fund early-career investigators and collaborative science teams to launch the CZI Neurodegeneration Challenge Network. “I am honored to receive this prestigious award and look forward to working closely with my colleagues in an effort to reach scientific breakthroughs that will help millions of people suffering from these diseases,” said Dr. Marazzi. “CZI recognizes the importance of cross-disciplinary approaches to study neurodegenerative disorders and improve health for mankind.”

— Ivan Marazzi, PhD, Assistant Professor, Microbiology, Icahn School of Medicine at Mount Sinai

Learn more >

Additional coverage: BioPortfolio; International Business Times